Literature DB >> 12687457

Adrenomedullin and nitric oxide in children with detrusor instability.

Ayşe Balat1, Kemal Sarica, Mustafa Cekmen, Muhittin Yürekli, Faruk Yağci, Ahmet Erbağci.   

Abstract

Detrusor instability (DI) and detrusor-external sphincter dyssynergia lead to poor bladder emptying and high bladder pressure. Recent results indicate that nitric oxide (NO) is an important transmitter or messenger molecule in autonomic neurotransmission. Adrenomedullin (AM) is a potent vasodilator and natriuretic peptide, originally purified from human pheochromocytoma. Since NO and AM have vasodilatory effects on smooth muscles, we considered them to be of interest in children with DI. We determined the tissue levels of NO and AM in 14 children with DI, and compared these with 6 children with normal bladder activity. Bladder biopsy total nitrite levels (nmol/g tissue) were decreased in children with DI (10.69+/-0.91 vs. 12.83+/-0.98, P<0.01). However, AM levels (pmol/g tissue) were increased in the same patients (48.84+/-3.52 vs. 28.79+/-1.53, P<0.001). According to our results, decreased NO production probably has a role in the pathophysiology of DI, although increased AM appears to be compensatory. NO may provide a therapeutic target in clinical situations related to DI. However, the functional significance of AM and NO in bladder smooth muscle remains to be determined by further detailed studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687457     DOI: 10.1007/s00467-003-1125-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  39 in total

1.  Biofeedback training for detrusor overactivity in children.

Authors:  T Yamanishi; K Yasuda; N Murayama; R Sakakibara; T Uchiyama; H Ito
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

Review 2.  Adrenomedullin and the control of fluid and electrolyte homeostasis.

Authors:  W K Samson
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

Review 3.  The L-arginine/nitric oxide pathway and non-adrenergic, non-cholinergic relaxation of the lower urinary tract.

Authors:  K E Andersson; K Persson
Journal:  Gen Pharmacol       Date:  1993-07

4.  Nitric oxide increases adrenomedullin receptor function in rat mesangial cells.

Authors:  Jörg Dötsch; Ellen Schoof; Harald O Schöcklmann; Bernhard Brüne; Ina Knerr; Reinald Repp; Wolfgang Rascher
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

5.  The relaxant effect of adrenomedullin on particular smooth muscles despite a general expression of its mRNA in smooth muscle, endothelial and epithelial cells.

Authors:  J Nishimura; H Seguchi; C Sakihara; Y Kureishi; H Yoshimura; S Kobayashi; H Kanaide
Journal:  Br J Pharmacol       Date:  1997-01       Impact factor: 8.739

6.  Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation.

Authors:  M J James; A T Birmingham; S J Hill
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

7.  Capsaicin-induced nitric-oxide-dependent relaxation in isolated dog urethra.

Authors:  S Nishizawa; Y Igawa; N Okada; T Ohhashi
Journal:  Eur J Pharmacol       Date:  1997-09-24       Impact factor: 4.432

8.  Biofeedback treatment of children and adults with idiopathic detrusor instability.

Authors:  D Kjølseth; B Madsen; L M Knudsen; J P Nørgaard; J C Djurhuus
Journal:  Scand J Urol Nephrol       Date:  1994-09

9.  Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum.

Authors:  P A Bush; W J Aronson; G M Buga; J Rajfer; L J Ignarro
Journal:  J Urol       Date:  1992-06       Impact factor: 7.450

10.  Effects of nitric oxide on detrusor relaxation.

Authors:  B H Chung; S K Choi; K C Chang
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450

View more
  1 in total

Review 1.  A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker.

Authors:  Anna Solé-Ribalta; Sara Bobillo-Pérez; Iolanda Jordan-García
Journal:  Children (Basel)       Date:  2022-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.